Adverse drug reactions - a podcast by BMJ Group
from 2018-11-06T15:53:33
::
::
Clinical trials for regulatory approval are designed to test efficacy, but new drugs might have adverse reactions - reactions those trials aren’t designed to spot.
To talk about those adverse reactions - how to spot them, how to report them and what to do about them, we're joined by Robin Ferner, from the West Midlands Centre for Adverse Drug Reactions.Read the full practice article:
https://www.bmj.com/content/363/bmj.k4051
Further episodes of The BMJ Podcast
Further podcasts by BMJ Group
Website of BMJ Group